• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDC20介导的hnRNPU泛素化调控染色质凝聚及抗癌药物反应。

CDC20-Mediated hnRNPU Ubiquitination Regulates Chromatin Condensation and Anti-Cancer Drug Response.

作者信息

Wavelet-Vermuse Cindy, Odnokoz Olena, Xue Yifan, Lu Xinghua, Cristofanilli Massimo, Wan Yong

机构信息

Department of Pharmacology and Chemical Biology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.

Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15206, USA.

出版信息

Cancers (Basel). 2022 Jul 31;14(15):3732. doi: 10.3390/cancers14153732.

DOI:10.3390/cancers14153732
PMID:35954396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9367339/
Abstract

Cell division cycle 20 (CDC20) functions as a critical cell cycle regulator. It plays an important role in cancer development and drug resistance. However, the molecular mechanisms by which CDC20 regulates cellular drug response remain poorly understood. Chromatin-associated CDC20 interactome in breast cancer cells was analyzed by using affinity purification coupled with mass spectrometry. hnRNPU as a CDC20 binding partner was validated by co-immunoprecipitation and immunostaining. The molecular domain, comprising amino acid residues 461-653, on hnRNPU required for its interaction with CDC20 was identified by mapping of interactions. Co-immunoprecipitation showed that CDC20-mediated hnRNPU ubiquitination promotes its interaction with the CTCF and cohesin complex. The effects of CDC20-hnRNPU on nuclear size and chromatin condensation were investigated by analyzing DAPI and H2B-mCherry staining, respectively. The role of CDC20-hnRNPU in tumor progression and drug resistance was examined by CCK-8 cell survival and clonogenic assays. Our study indicates that CDC20-mediated ubiquitination of hnRNPU modulates chromatin condensation by regulating the interaction between hnRNPU and the CTCF-cohesin complex. Dysregulation of the CDC20-hnRNPU axis contributes to tumor progression and drug resistance.

摘要

细胞分裂周期20(CDC20)作为一种关键的细胞周期调节因子发挥作用。它在癌症发展和耐药性中起着重要作用。然而,CDC20调节细胞药物反应的分子机制仍知之甚少。通过使用亲和纯化结合质谱分析乳腺癌细胞中与染色质相关的CDC20相互作用组。通过共免疫沉淀和免疫染色验证了hnRNPU作为CDC20结合伴侣。通过相互作用图谱鉴定了hnRNPU与CDC20相互作用所需的包含氨基酸残基461 - 653的分子结构域。共免疫沉淀表明,CDC20介导的hnRNPU泛素化促进其与CTCF和黏连蛋白复合物的相互作用。分别通过分析DAPI和H2B - mCherry染色研究了CDC20 - hnRNPU对核大小和染色质凝聚的影响。通过CCK - 8细胞存活和克隆形成试验检测了CDC20 - hnRNPU在肿瘤进展和耐药性中的作用。我们的研究表明,CDC20介导的hnRNPU泛素化通过调节hnRNPU与CTCF - 黏连蛋白复合物之间的相互作用来调节染色质凝聚。CDC20 - hnRNPU轴的失调导致肿瘤进展和耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/06e4d24921f8/cancers-14-03732-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/618747efe251/cancers-14-03732-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/1619babf6303/cancers-14-03732-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/4f64a6f117e8/cancers-14-03732-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/a304315ed32a/cancers-14-03732-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/9e07adf36238/cancers-14-03732-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/a24503803dbb/cancers-14-03732-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/06e4d24921f8/cancers-14-03732-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/618747efe251/cancers-14-03732-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/1619babf6303/cancers-14-03732-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/4f64a6f117e8/cancers-14-03732-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/a304315ed32a/cancers-14-03732-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/9e07adf36238/cancers-14-03732-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/a24503803dbb/cancers-14-03732-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0048/9367339/06e4d24921f8/cancers-14-03732-g007.jpg

相似文献

1
CDC20-Mediated hnRNPU Ubiquitination Regulates Chromatin Condensation and Anti-Cancer Drug Response.CDC20介导的hnRNPU泛素化调控染色质凝聚及抗癌药物反应。
Cancers (Basel). 2022 Jul 31;14(15):3732. doi: 10.3390/cancers14153732.
2
circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression.环状 hnRNPU 通过抑制 NONO 介导的 c-Myc 反式激活和 mRNA 稳定来抑制糖基化和肿瘤进展所必需的。
J Exp Clin Cancer Res. 2023 Nov 23;42(1):313. doi: 10.1186/s13046-023-02898-5.
3
The nuclear matrix protein HNRNPU maintains 3D genome architecture globally in mouse hepatocytes.核基质蛋白 HNRNPU 全局性地维持小鼠肝细胞中的三维基因组结构。
Genome Res. 2018 Feb;28(2):192-202. doi: 10.1101/gr.224576.117. Epub 2017 Dec 22.
4
CDC20 promotes bone formation via APC/C dependent ubiquitination and degradation of p65.CDC20 通过 APC/C 依赖性泛素化和 p65 的降解促进骨形成。
EMBO Rep. 2021 Sep 6;22(9):e52576. doi: 10.15252/embr.202152576. Epub 2021 Aug 12.
5
A novel strategy to block mitotic progression for targeted therapy.一种用于靶向治疗的阻断有丝分裂进程的新策略。
EBioMedicine. 2019 Nov;49:40-54. doi: 10.1016/j.ebiom.2019.10.013. Epub 2019 Oct 25.
6
USP13 interacts with cohesin and regulates its ubiquitination in human cells.USP13在人类细胞中与黏连蛋白相互作用并调节其泛素化。
J Biol Chem. 2021 Jan-Jun;296:100194. doi: 10.1074/jbc.RA120.015762. Epub 2020 Dec 20.
7
HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.HNF4A-AS1/hnRNPU/CTCF 轴作为有氧糖酵解和神经母细胞瘤进展的治疗靶点。
J Hematol Oncol. 2020 Mar 26;13(1):24. doi: 10.1186/s13045-020-00857-7.
8
Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex.Cdc20 通过后期促进复合物(anaphase promoting complex)指导肿瘤抑制因子 SMAR1 的蛋白酶体介导的降解,在癌症的较高级别中起作用。
Cell Death Dis. 2017 Jun 15;8(6):e2882. doi: 10.1038/cddis.2017.270.
9
ATP depletion during mitotic arrest induces mitotic slippage and APC/C-dependent cyclin B1 degradation.有丝分裂阻滞期间的 ATP 耗竭会诱导有丝分裂滑脱和 APC/C 依赖性细胞周期蛋白 B1 的降解。
Exp Mol Med. 2018 Apr 27;50(4):1-14. doi: 10.1038/s12276-018-0069-2.
10
CDC20 maintains tumor initiating cells.细胞分裂周期蛋白20维持肿瘤起始细胞。
Oncotarget. 2015 May 30;6(15):13241-54. doi: 10.18632/oncotarget.3676.

引用本文的文献

1
TRIM8 promotes ovarian cancer proliferation and migration by targeting VDAC2 for ubiquitination and degradation.TRIM8 通过靶向 VDAC2 进行泛素化和降解促进卵巢癌细胞增殖和迁移。
Cancer Med. 2024 Jun;13(11):e7396. doi: 10.1002/cam4.7396.
2
Biological functions and clinic significance of SAF‑A (Review).SAF-A的生物学功能及临床意义(综述)
Biomed Rep. 2024 Apr 10;20(6):88. doi: 10.3892/br.2024.1776. eCollection 2024 Jun.
3
Prognostic and Immune Landscape Analysis of Ubiquitination-related Genes in Hepatocellular Carcinoma: Based on Bulk and Single-cell RNA Sequencing Data.

本文引用的文献

1
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies.CDK20 在有丝分裂内外:血液系统恶性肿瘤的预后因素和治疗靶点。
J Exp Clin Cancer Res. 2022 Apr 30;41(1):159. doi: 10.1186/s13046-022-02363-9.
2
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.靶向 HNRNPU 克服膀胱癌顺铂耐药性。
Mol Cancer. 2022 Feb 7;21(1):37. doi: 10.1186/s12943-022-01517-9.
3
The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors.通过对人类肿瘤的综合泛癌分析揭示APC/C激活蛋白Cdc20的致癌作用
肝细胞癌中泛素化相关基因的预后及免疫图谱分析:基于批量和单细胞RNA测序数据
J Cancer. 2024 Mar 11;15(9):2580-2600. doi: 10.7150/jca.93425. eCollection 2024.
4
Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning.通过机器学习探索乳腺癌的预后基因因素。
Biochem Genet. 2024 Dec;62(6):5022-5050. doi: 10.1007/s10528-024-10712-w. Epub 2024 Feb 21.
5
Insights on epithelial cells at the single-cell level in hepatocellular carcinoma prognosis and response to chemotherapy.肝细胞癌预后及化疗反应中单细胞水平上皮细胞的见解
Front Pharmacol. 2023 Nov 17;14:1292831. doi: 10.3389/fphar.2023.1292831. eCollection 2023.
6
Functional analysis of recurrent CDC20 promoter variants in human melanoma.人类黑色素瘤中反复出现的 CDC20 启动子变异体的功能分析。
Commun Biol. 2023 Nov 29;6(1):1216. doi: 10.1038/s42003-023-05526-2.
7
Therapeutic targeting of the TPX2/TTK network in colorectal cancer.靶向结直肠癌中 TPX2/TTK 网络的治疗。
Cell Commun Signal. 2023 Sep 28;21(1):265. doi: 10.1186/s12964-023-01290-2.
8
Structure-based virtual screening for identification of potential CDC20 inhibitors and their therapeutic evaluation in breast cancer.基于结构的虚拟筛选以鉴定潜在的细胞分裂周期蛋白20(CDC20)抑制剂及其在乳腺癌中的治疗评估
3 Biotech. 2023 May;13(5):141. doi: 10.1007/s13205-023-03554-7. Epub 2023 Apr 26.
Front Oncol. 2021 Aug 30;11:721797. doi: 10.3389/fonc.2021.721797. eCollection 2021.
4
Oscillation of Cdc20-APC/C-mediated CAMDI stability is critical for cortical neuron migration.Cdc20-APC/C 介导的 CAMDI 稳定性的振荡对于皮质神经元迁移至关重要。
J Biol Chem. 2021 Aug;297(2):100986. doi: 10.1016/j.jbc.2021.100986. Epub 2021 Jul 21.
5
Correlation AnalyzeR: functional predictions from gene co-expression correlations.Correlation AnalyzeR:基于基因共表达相关性的功能预测。
BMC Bioinformatics. 2021 Apr 20;22(1):206. doi: 10.1186/s12859-021-04130-7.
6
Identification of therapeutic targets and prognostic biomarkers from the hnRNP family in invasive breast carcinoma.从浸润性乳腺癌的 hnRNP 家族中鉴定治疗靶点和预后生物标志物。
Aging (Albany NY). 2021 Jan 20;13(3):4503-4521. doi: 10.18632/aging.202411.
7
Downregulation of CDC20 suppressed cell proliferation, induced apoptosis, triggered cell cycle arrest in osteosarcoma cells, and enhanced chemosensitivity to cisplatin.细胞分裂周期蛋白20(CDC20)的下调抑制了骨肉瘤细胞的增殖,诱导了细胞凋亡,引发了细胞周期停滞,并增强了对顺铂的化疗敏感性。
Neoplasma. 2021 Mar;68(2):382-390. doi: 10.4149/neo_2020_200614N629. Epub 2020 Oct 30.
8
MDM2-P53 Signaling Pathway-Mediated Upregulation of CDC20 Promotes Progression of Human Diffuse Large B-Cell Lymphoma.MDM2-P53信号通路介导的CDC20上调促进人弥漫性大B细胞淋巴瘤进展。
Onco Targets Ther. 2020 Oct 15;13:10475-10487. doi: 10.2147/OTT.S253758. eCollection 2020.
9
Landscape of cohesin-mediated chromatin loops in the human genome.人类基因组中黏合蛋白介导的染色质环景观。
Nature. 2020 Jul;583(7818):737-743. doi: 10.1038/s41586-020-2151-x. Epub 2020 Jul 29.
10
Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer.CDK7 阻断可逆转乳腺癌内分泌治疗耐药。
Int J Mol Sci. 2020 Apr 23;21(8):2974. doi: 10.3390/ijms21082974.